ZNTL Key Metrics | Stock Alarm Pro

Sign In Create Free Alerts

Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ

Loading

Overview Intelligence Charts News Fundamentals Key Metrics Earnings Growth Financials Insiders

Key Metrics

As of 2024• vs 2023

Core Metrics

Market Cap

$215.37M-78.3%

Interest Coverage

Per Share

Revenue/Share

$0.95

Net Income/Share

$-2.33+47.8%

Operating CF/Share

$-2.40+24.3%

Free CF/Share

$-2.41+24.5%

Cash/Share

$5.22-29.3%

Book Value/Share

$4.74-29.1%

Tangible Book/Share

$4.74-28.4%

Equity/Share

$4.74-29.0%

Interest Debt/Share

$0.60-14.3%

Valuation

Market Cap

$215.37M-78.3%

Enterprise Value

$224.12M-77.8%

P/OCF Ratio

-1.26+73.6%

P/FCF Ratio

-1.26+73.5%

P/TB Ratio

0.64-71.8%

EV/EBITDA

-1.20+70.4%

Profitability

Return on Tangible Assets

Capital Allocation

CapEx/OCF

-0.13%+53.9%

CapEx/Revenue

0.33%

CapEx/Depreciation

0.17-59.2%

SBC/Revenue

99.77%

Balance Sheet

Net Debt/EBITDA

-0.05+34.4%

Interest Coverage

Efficiency

Days Sales Outstanding

27 days

Days Payables Outstanding

0 days

Days Inventory

0 days

Receivables Turnover

13.48x

Payables Turnover

0.00x

Inventory Turnover

0.00x

Special Valuations

Graham Number

--

Graham Net-Net

$3.96-27.7%

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance